Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 6.71
(0.3%)
CNY 6.71
(0.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1 Billion CNY | 0.31% |
| 2022 | 861.36 Million CNY | 18.49% |
| 2021 | 726.97 Million CNY | 16.31% |
| 2020 | 625.04 Million CNY | -13.01% |
| 2019 | 718.48 Million CNY | 13.29% |
| 2018 | 634.19 Million CNY | 62.57% |
| 2017 | 390.11 Million CNY | 6.31% |
| 2016 | 366.96 Million CNY | -3.23% |
| 2015 | 379.19 Million CNY | 54.9% |
| 2014 | 244.8 Million CNY | 89.01% |
| 2013 | 129.52 Million CNY | -9.01% |
| 2012 | 142.34 Million CNY | 36.11% |
| 2011 | 104.58 Million CNY | 12.85% |
| 2010 | 92.67 Million CNY | 24.99% |
| 2009 | 74.14 Million CNY | 11.39% |
| 2008 | 66.56 Million CNY | 16.58% |
| 2007 | 57.1 Million CNY | 46.04% |
| 2006 | 39.09 Million CNY | -18.33% |
| 2005 | 47.87 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 213.79 Million CNY | -2.9% |
| 2024 Q3 | 253.96 Million CNY | -61.61% |
| 2024 Q2 | 299.94 Million CNY | 40.29% |
| 2023 Q4 | 220.19 Million CNY | -4.73% |
| 2023 Q3 | 231.13 Million CNY | 3.37% |
| 2023 Q2 | 223.6 Million CNY | -4.19% |
| 2023 FY | 864 Million CNY | 0.31% |
| 2023 Q1 | 233.37 Million CNY | 1.34% |
| 2022 Q2 | 208.95 Million CNY | 7.94% |
| 2022 FY | 861.36 Million CNY | 18.49% |
| 2022 Q4 | 230.28 Million CNY | 0.76% |
| 2022 Q1 | 193.58 Million CNY | -13.26% |
| 2022 Q3 | 228.53 Million CNY | 9.37% |
| 2021 FY | 726.97 Million CNY | 16.31% |
| 2021 Q2 | 146.21 Million CNY | -4.23% |
| 2021 Q1 | 152.66 Million CNY | -28.18% |
| 2021 Q4 | 223.18 Million CNY | 8.91% |
| 2021 Q3 | 204.91 Million CNY | 40.15% |
| 2020 FY | 625.04 Million CNY | -13.01% |
| 2020 Q4 | 212.58 Million CNY | 38.1% |
| 2020 Q1 | 133.46 Million CNY | -39.0% |
| 2020 Q2 | 119.06 Million CNY | -10.79% |
| 2020 Q3 | 153.93 Million CNY | 29.29% |
| 2019 Q1 | 156.26 Million CNY | -35.89% |
| 2019 FY | 718.48 Million CNY | 13.29% |
| 2019 Q4 | 218.77 Million CNY | 21.98% |
| 2019 Q3 | 179.35 Million CNY | 10.95% |
| 2019 Q2 | 161.64 Million CNY | 3.44% |
| 2018 Q1 | 105.39 Million CNY | -11.95% |
| 2018 Q3 | 167.84 Million CNY | 43.24% |
| 2018 Q2 | 117.17 Million CNY | 11.18% |
| 2018 Q4 | 243.76 Million CNY | 45.23% |
| 2018 FY | 634.19 Million CNY | 62.57% |
| 2017 Q4 | 119.7 Million CNY | 15.52% |
| 2017 Q2 | 90.42 Million CNY | 18.41% |
| 2017 Q1 | 76.36 Million CNY | -44.53% |
| 2017 FY | 390.11 Million CNY | 6.31% |
| 2017 Q3 | 103.62 Million CNY | 14.59% |
| 2016 Q2 | 76.35 Million CNY | 2.93% |
| 2016 Q3 | 78.76 Million CNY | 3.16% |
| 2016 Q4 | 137.67 Million CNY | 74.79% |
| 2016 FY | 366.96 Million CNY | -3.23% |
| 2016 Q1 | 74.17 Million CNY | -48.61% |
| 2015 Q3 | 85.37 Million CNY | 15.3% |
| 2015 Q4 | 144.32 Million CNY | 69.05% |
| 2015 Q2 | 74.04 Million CNY | -1.86% |
| 2015 Q1 | 75.44 Million CNY | -19.9% |
| 2015 FY | 379.19 Million CNY | 54.9% |
| 2014 Q1 | 54.62 Million CNY | 105.49% |
| 2014 Q3 | 47.17 Million CNY | -1.06% |
| 2014 FY | 244.8 Million CNY | 89.01% |
| 2014 Q4 | 94.19 Million CNY | 99.66% |
| 2014 Q2 | 47.68 Million CNY | -12.71% |
| 2013 Q4 | 26.58 Million CNY | -20.24% |
| 2013 FY | 129.52 Million CNY | -9.01% |
| 2013 Q3 | 33.32 Million CNY | -23.16% |
| 2013 Q2 | 43.37 Million CNY | 65.35% |
| 2013 Q1 | 26.23 Million CNY | -49.78% |
| 2012 Q1 | 17.49 Million CNY | -56.64% |
| 2012 Q2 | 42.17 Million CNY | 141.03% |
| 2012 Q3 | 30.43 Million CNY | -27.85% |
| 2012 Q4 | 52.23 Million CNY | 71.66% |
| 2012 FY | 142.34 Million CNY | 36.11% |
| 2011 Q3 | 22.55 Million CNY | 6.31% |
| 2011 Q2 | 21.21 Million CNY | 3.77% |
| 2011 Q1 | 20.44 Million CNY | -16.34% |
| 2011 FY | 104.58 Million CNY | 12.85% |
| 2011 Q4 | 40.35 Million CNY | 78.89% |
| 2010 Q3 | 31.07 Million CNY | 81.01% |
| 2010 FY | 92.67 Million CNY | 24.99% |
| 2010 Q2 | 17.16 Million CNY | -14.15% |
| 2010 Q1 | 19.99 Million CNY | -15.93% |
| 2010 Q4 | 24.44 Million CNY | -21.34% |
| 2009 Q1 | 15.68 Million CNY | -22.97% |
| 2009 Q3 | 16.8 Million CNY | -6.01% |
| 2009 Q4 | 23.78 Million CNY | 41.56% |
| 2009 FY | 74.14 Million CNY | 11.39% |
| 2009 Q2 | 17.87 Million CNY | 13.97% |
| 2008 FY | 66.56 Million CNY | 16.58% |
| 2008 Q4 | 20.36 Million CNY | 37.63% |
| 2008 Q3 | 14.79 Million CNY | 3.7% |
| 2008 Q2 | 14.26 Million CNY | -16.79% |
| 2008 Q1 | 17.14 Million CNY | -16.13% |
| 2007 FY | 57.1 Million CNY | 46.04% |
| 2007 Q1 | 16.97 Million CNY | 0.0% |
| 2007 Q3 | 8.83 Million CNY | -18.54% |
| 2007 Q4 | 20.44 Million CNY | 131.35% |
| 2007 Q2 | 10.84 Million CNY | -36.11% |
| 2006 FY | 39.09 Million CNY | -18.33% |
| 2005 FY | 47.87 Million CNY | 0.0% |